2-((3-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propyl)thio)benzoic acid, 5mg

2-(2-Amino-1,3-thiazol-4-yl)-N-methylacetamide, 95.0%, 1g

Ethyl 4-aminopyrimidine-5-carboxylate, 95.0%, 250mg

tert-Butyl 4-[(3-nitropyridin-2-yloxy)methyl]piperidine-1-carboxylate, 95.0%, 1g

Sodium methoxide, 25% in methanol, 24.5-26.0 wt%, 100g

8-Nitroquinolin-2(1H)-one, 95.0%, 250mg

(butan-2-yl)[(2E)-2-(phenylmethylidene)heptyl]amine, 95.0%, 10g

ULTROXA(regR) Poly(2-methyl-2-oxazoline) (n=approx. 100)200mg

4-Chlorobenzo[b]thiophene, 95.0%, 5g

2-tert-Butyl-6-(3-tert-Butyl-2-hydroxy-5-methoxyphenyl)-4-methoxyphenol, 95+%, 250mg

N1-Benzyl-N1,N3,N3-tris(pyridin-2-ylmethyl)propane-1,3-diamine, 98%, 10g

2,3,5,6-Tetrafluorobenzoic Acid>98.0%(GC)(T)1g

1-Bromo-2,3,5-trichlorobenzene, 95.0%, 100g